ES2102836T3 - El empleo de vacunas antihelminticas en el control de la enfermedad parasitaria asociada con la perdida de la inmunidad natural. - Google Patents
El empleo de vacunas antihelminticas en el control de la enfermedad parasitaria asociada con la perdida de la inmunidad natural.Info
- Publication number
- ES2102836T3 ES2102836T3 ES94906969T ES94906969T ES2102836T3 ES 2102836 T3 ES2102836 T3 ES 2102836T3 ES 94906969 T ES94906969 T ES 94906969T ES 94906969 T ES94906969 T ES 94906969T ES 2102836 T3 ES2102836 T3 ES 2102836T3
- Authority
- ES
- Spain
- Prior art keywords
- helminth
- loss
- natural immunity
- control
- antihelmintic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000004719 natural immunity Effects 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 208000030852 Parasitic disease Diseases 0.000 title 1
- 230000000507 anthelmentic effect Effects 0.000 title 1
- 244000000013 helminth Species 0.000 abstract 5
- 108010034145 Helminth Proteins Proteins 0.000 abstract 2
- 241000243976 Haemonchus Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241001494479 Pecora Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000001010 compromised effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 201000005193 ostertagiasis Diseases 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA INVENCION PROPORCIONA UNA UTILIZACION DE UN ANTIGENO OCULTO DE HELMINTO, O FRAGMENTOS ANTIGENICOS, PRECURSORES Y DERIVADOS FUNCIONALMENTE EQUIVALENTES O VARIANTES DE LOS MISMOS QUE TIENEN ACTIVIDAD INMUNOGENICA FRENTE A UNO O MAS PARASITOS HELMINTOS, EN LA FABRICACION DE UNA COMPOSICION DE VACUNA PARA LA ADMINISTRACION A UN ANIMAL AL MENOS UNA VEZ ANTES DE Y/O DURANTE UN PERIODO DE PERDIDA O ADVERTENCIA DE LA INMUNIDAD NATURAL A LOS PARASITOS HELMINTOS GASTRO-INTESTINALES, PARA ASI ESTIMULAR LA INMUNIDAD PROTECTORA FRENTE A DICHOS PARASITOS HELMINTOS DURANTE EL PERIODO DE LA INMUNIDAD NATURAL COMPROMETIDA. LA INVENCION TIENE UNA UTILIDAD PARTICULAR EN EL CONTROL DE LA ELEVACION PERIPARTURIENTA DE NEMATODO HELMINTO HAEMONCHUS EN OVEJAS, Y DE OSTERTAGIASIS TIPO II.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939303681A GB9303681D0 (en) | 1993-02-24 | 1993-02-24 | Vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2102836T3 true ES2102836T3 (es) | 1997-08-01 |
Family
ID=10730938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94906969T Expired - Lifetime ES2102836T3 (es) | 1993-02-24 | 1994-02-23 | El empleo de vacunas antihelminticas en el control de la enfermedad parasitaria asociada con la perdida de la inmunidad natural. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0686041B1 (es) |
| JP (1) | JPH08506828A (es) |
| AT (1) | ATE152916T1 (es) |
| AU (1) | AU679494B2 (es) |
| BG (1) | BG61934B1 (es) |
| CA (1) | CA2155119A1 (es) |
| CZ (1) | CZ213895A3 (es) |
| DE (1) | DE69403197T2 (es) |
| ES (1) | ES2102836T3 (es) |
| GB (1) | GB9303681D0 (es) |
| HU (1) | HUT72919A (es) |
| MX (1) | MX9401384A (es) |
| NO (1) | NO953311L (es) |
| NZ (1) | NZ261598A (es) |
| RU (1) | RU2145876C1 (es) |
| WO (1) | WO1994019010A1 (es) |
| ZA (1) | ZA941237B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0815674D0 (en) * | 2008-08-28 | 2008-10-08 | Moredun Res Inst | Nematode vaccine |
| PE20221278A1 (es) | 2019-11-04 | 2022-09-05 | Revolution Medicines Inc | Inhibidores de ras |
| TW202340214A (zh) | 2021-12-17 | 2023-10-16 | 美商健臻公司 | 做為shp2抑制劑之吡唑并吡𠯤化合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8906156D0 (en) * | 1989-03-17 | 1989-05-04 | Munn Edward A | Production and use of anthelmintic agents and protective immunogens |
| GB9209993D0 (en) * | 1992-05-08 | 1992-06-24 | Munn Edward A | Vaccines |
| ZW8893A1 (en) * | 1992-07-21 | 1994-06-01 | Pitman Moore Inc | Vaccines |
-
1993
- 1993-02-24 GB GB939303681A patent/GB9303681D0/en active Pending
-
1994
- 1994-02-23 AU AU60415/94A patent/AU679494B2/en not_active Ceased
- 1994-02-23 DE DE69403197T patent/DE69403197T2/de not_active Expired - Fee Related
- 1994-02-23 RU RU95118396A patent/RU2145876C1/ru active
- 1994-02-23 ES ES94906969T patent/ES2102836T3/es not_active Expired - Lifetime
- 1994-02-23 HU HU9502467A patent/HUT72919A/hu unknown
- 1994-02-23 WO PCT/GB1994/000354 patent/WO1994019010A1/en not_active Application Discontinuation
- 1994-02-23 MX MX9401384A patent/MX9401384A/es not_active IP Right Cessation
- 1994-02-23 CA CA002155119A patent/CA2155119A1/en not_active Abandoned
- 1994-02-23 AT AT94906969T patent/ATE152916T1/de not_active IP Right Cessation
- 1994-02-23 ZA ZA941237A patent/ZA941237B/xx unknown
- 1994-02-23 NZ NZ261598A patent/NZ261598A/en unknown
- 1994-02-23 JP JP6518763A patent/JPH08506828A/ja active Pending
- 1994-02-23 EP EP94906969A patent/EP0686041B1/en not_active Expired - Lifetime
- 1994-02-23 CZ CZ952138A patent/CZ213895A3/cs unknown
-
1995
- 1995-08-23 NO NO953311A patent/NO953311L/no unknown
- 1995-08-28 BG BG99888A patent/BG61934B1/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9303681D0 (en) | 1993-04-14 |
| ZA941237B (en) | 1994-09-19 |
| MX9401384A (es) | 1994-08-31 |
| WO1994019010A1 (en) | 1994-09-01 |
| NO953311D0 (no) | 1995-08-23 |
| NO953311L (no) | 1995-10-19 |
| JPH08506828A (ja) | 1996-07-23 |
| ATE152916T1 (de) | 1997-05-15 |
| NZ261598A (en) | 1997-03-24 |
| CZ213895A3 (en) | 1996-03-13 |
| EP0686041B1 (en) | 1997-05-14 |
| HUT72919A (en) | 1996-06-28 |
| CA2155119A1 (en) | 1994-09-01 |
| HU9502467D0 (en) | 1995-10-30 |
| BG99888A (bg) | 1996-04-30 |
| RU2145876C1 (ru) | 2000-02-27 |
| AU679494B2 (en) | 1997-07-03 |
| DE69403197D1 (de) | 1997-06-19 |
| AU6041594A (en) | 1994-09-14 |
| EP0686041A1 (en) | 1995-12-13 |
| DE69403197T2 (de) | 1997-08-28 |
| BG61934B1 (bg) | 1998-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2030124T3 (es) | Dispositivo para la aplicacion de implantes. | |
| BR0107972A (pt) | Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano | |
| ES2152421T3 (es) | Vacunas de conjugados polisacarido neumococcico-neumolisina recombinante para la inmunizacion contra las infecciones neumococcicas. | |
| NO20015073D0 (no) | Vaksiner | |
| PT714444E (pt) | Atenuacao de um epitopo imunodominante de um antigenio para utilizacao em vacinas e imunoterapias para plantas, animais e homens | |
| LV10203A (lv) | Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts | |
| ATE127345T1 (de) | Stressproteine und verwendungen dafür. | |
| ATE350057T1 (de) | Impfstoffzusammesetzung | |
| ES2070266T3 (es) | Vacuna contra la infeccion por escherichia coli. | |
| AR008799A1 (es) | Composicion de vacuna para prevenir o tratar el paludismo; uso de dicha composicion para elaborar medicamentos y metodo para dicha profilaxis y dichotratamiento | |
| PT1024824E (pt) | Composicao de vacina dispersivel solida para administracao oral | |
| BR9704879A (pt) | Composição de vacina e uso de um vírus cav vivo | |
| ES2102836T3 (es) | El empleo de vacunas antihelminticas en el control de la enfermedad parasitaria asociada con la perdida de la inmunidad natural. | |
| ES2136064T3 (es) | Vacunas de toxoide de pasteurella multocida. | |
| KR890006253A (ko) | 가금류내의 E.coli septicaemia에 대한 백신 | |
| ES2079851T3 (es) | Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas. | |
| ES2166763T3 (es) | Inmunizacion parenteral contra rotavirus. | |
| AR010568A1 (es) | Polipeptido, composicion de vacuna, uso del polipeptido en la fabricacion de una composicion, y metodo para producir en un mamifero una respuestainmuno-protectora contra la infeccion de helicobacter pylori | |
| PT636030E (pt) | Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1 | |
| ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form | |
| AR020022A1 (es) | COMPOSICIONES DE ANTíGENOS DE ERYSILOPELOTHRIX RHUSIOPATHIAE, SU USO EN LA PREPARACIoN DE MEDICAMENTOS Y COMPOSICIONES DE VACUNAS. | |
| DE69123252D1 (de) | Kreuzreaktive immunisierung gegen influenza | |
| UA49145A (uk) | Спосіб стандартизації моделювання проникної інфікованої травми заднього сегмента ока |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 686041 Country of ref document: ES |